- Home
- OLMA vs MXCT Comparison
OLMA vs MXCT Comparison
Compare OLMA & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- MXCT
- Stock Information
- Founded
- OLMA 2006
- MXCT 1999
- Country
- OLMA United States
- MXCT United States
- Employees
- OLMA N/A
- MXCT N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- OLMA Health Care
- MXCT Health Care
- Exchange
- OLMA Nasdaq
- MXCT Nasdaq
- Market Cap
- OLMA 289.0M
- MXCT 275.7M
- IPO Year
- OLMA 2020
- MXCT 2021
- Fundamental
- Price
- OLMA $4.60
- MXCT $2.36
- Analyst Decision
- OLMA Strong Buy
- MXCT Strong Buy
- Analyst Count
- OLMA 3
- MXCT 1
- Target Price
- OLMA $27.67
- MXCT $9.00
- AVG Volume (30 Days)
- OLMA 848.8K
- MXCT 734.8K
- Earning Date
- OLMA 05-16-2025
- MXCT 05-07-2025
- Dividend Yield
- OLMA N/A
- MXCT N/A
- EPS Growth
- OLMA N/A
- MXCT N/A
- EPS
- OLMA N/A
- MXCT N/A
- Revenue
- OLMA N/A
- MXCT $37,675,000.00
- Revenue This Year
- OLMA N/A
- MXCT $9.05
- Revenue Next Year
- OLMA N/A
- MXCT $19.98
- P/E Ratio
- OLMA N/A
- MXCT N/A
- Revenue Growth
- OLMA N/A
- MXCT N/A
- 52 Week Low
- OLMA $2.86
- MXCT $2.21
- 52 Week High
- OLMA $16.62
- MXCT $5.26
- Technical
- Relative Strength Index (RSI)
- OLMA 49.07
- MXCT 33.78
- Support Level
- OLMA $4.35
- MXCT $2.60
- Resistance Level
- OLMA $5.74
- MXCT $2.86
- Average True Range (ATR)
- OLMA 0.39
- MXCT 0.15
- MACD
- OLMA -0.05
- MXCT -0.02
- Stochastic Oscillator
- OLMA 17.99
- MXCT 9.77
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.